Johnson & Johnson has agreed to the divestiture of its entire trauma business in the European Economic Area to remove overlap in trauma devices as a result of the acquisition. On that basis, the Commission cleared the transition.
A likely recipient of the company’s DePuy trauma business is Biomet, which placed a $280 million offer earlier this year.
More Articles on Orthopedic Devices:
Medtronic Launches Power Instruments for Spinal Surgery
Surgeons Report No Improvement in Joint Reconstruction Market
Tornier Consolidates Facilities to Save More Than $2M Per Year
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
